University of Texas Southwestern Medical Center: Prostatic Neoplasms trials

The registry lists 17 Prostatic Neoplasms studies with University of Texas Southwestern Medical Center as lead sponsor. 5 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 4Phase 2 6Phase 3 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy DeliveryNot yet recruitingNCT07674771Early Phase 1
• Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER)RecruitingNCT07313241Phase 2
• Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1RecruitingNCT06353321
• Outcomes of Focal Ablation for Prostate CancerRecruitingNCT05478694
• Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active SurveillanceRecruitingNCT03769766Phase 3
• Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal SpacerCompletedNCT02353832Phase 2Results posted
• Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate CancerCompletedNCT02064582Phase 2Results posted
• Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)CompletedNCT01818986Phase 2Results posted
• Stereotactic Body Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00547339Phase 1/2Results posted
• Periprostatic Neurolysis in Prostate CancerActive, not recruitingNCT07100847Phase 1
• UroLift System With SAbR for Prostate Cancer and BPHCompletedNCT05311527Not applicable
• Investigating Bone and Skeletal Muscle Interaction in Men With Prostate CancerCompletedNCT03386812
• Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate CancerActive, not recruitingNCT02353819Phase 1
• Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-IrradiationCompletedNCT02170181
• Circulating Tumor Cells in Prostate Cancer PatientsTerminatedNCT01414712
• Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After SurgeryWithdrawnNCT01079793Phase 1/2
• MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation TherapyWithdrawnNCT00963300Not applicable